Stock Track | Moderna Soars 5.41% Intraday on $50 Million CEPI Funding for Ebola Vaccine Development

Stock Track06-05

Moderna, Inc.'s stock surged 5.41% during intraday trading on Thursday, driven by positive news related to its vaccine development pipeline.

The rally followed the announcement that Moderna has expanded its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an mRNA-based vaccine candidate against the Bundibugyo Ebolavirus. CEPI has committed up to $50 million in funding to support the program's preclinical development and phase 1 clinical testing.

The funding is also designated to support parallel manufacturing activities during clinical evaluation. Positive early-stage safety and immunogenicity data could position the vaccine for advancement into large-scale phase 2/3 trials, providing a potential new avenue for growth in Moderna's infectious disease portfolio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159131020?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 00:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159131020","market":"hk","top_or_hot":-1,"title":"Stock Track | Moderna Soars 5.41% Intraday on $50 Million CEPI Funding for Ebola Vaccine Development","media":"Stock Track","content":"<p>Moderna, Inc.'s stock surged 5.41% during intraday trading on Thursday, driven by positive news related to its vaccine development pipeline.</p><p>The rally followed the announcement that Moderna has expanded its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an mRNA-based vaccine candidate against the Bundibugyo Ebolavirus. CEPI has committed up to $50 million in funding to support the program's preclinical development and phase 1 clinical testing.</p><p>The funding is also designated to support parallel manufacturing activities during clinical evaluation. Positive early-stage safety and immunogenicity data could position the vaccine for advancement into large-scale phase 2/3 trials, providing a potential new avenue for growth in Moderna's infectious disease portfolio.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5.41% Intraday on $50 Million CEPI Funding for Ebola Vaccine Development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5.41% Intraday on $50 Million CEPI Funding for Ebola Vaccine Development\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-06-05 00:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc.'s stock surged 5.41% during intraday trading on Thursday, driven by positive news related to its vaccine development pipeline.</p><p>The rally followed the announcement that Moderna has expanded its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an mRNA-based vaccine candidate against the Bundibugyo Ebolavirus. CEPI has committed up to $50 million in funding to support the program's preclinical development and phase 1 clinical testing.</p><p>The funding is also designated to support parallel manufacturing activities during clinical evaluation. Positive early-stage safety and immunogenicity data could position the vaccine for advancement into large-scale phase 2/3 trials, providing a potential new avenue for growth in Moderna's infectious disease portfolio.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1159131020","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159131020","pubTimestamp":1780592375,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc.'s stock surged 5.41% during intraday trading on Thursday, driven by positive news related to its vaccine development pipeline.The rally followed the announcement that Moderna has...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股追踪|Moderna盘中大涨5.41%CEPI融资5000万美元用于埃博拉疫苗研发","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc.'s stock surged 5.41% during intraday trading on Thursday, driven by positive news related to its vaccine development pipeline.The rally followed the announcement that Moderna has expanded its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an mRNA-based vaccine candidate against the Bundibugyo Ebolavirus. CEPI has committed up to $50 million in funding to support the program's preclinical development and phase 1 clinical testing.The funding is also designated to support parallel manufacturing activities during clinical evaluation. Positive early-stage safety and immunogenicity data could position the vaccine for advancement into large-scale phase 2/3 trials, providing a potential new avenue for growth in Moderna's infectious disease portfolio.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159131020","isCrawlerRequest":true}